Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Tax Rate (2016 - 2026)

Ani Pharmaceuticals' Tax Rate history spans 14 years, with the latest figure at 12.56% for Q4 2025.

  • On a quarterly basis, Tax Rate fell 1277.0% to 12.56% in Q4 2025 year-over-year; TTM through Dec 2025 was 18.2%, a 158.0% increase, with the full-year FY2025 number at 18.22%, up 161.0% from a year prior.
  • Tax Rate hit 12.56% in Q4 2025 for Ani Pharmaceuticals, down from 21.3% in the prior quarter.
  • Over the last five years, Tax Rate for ANIP hit a ceiling of 37.63% in Q3 2021 and a floor of 21.96% in Q4 2023.
  • Historically, Tax Rate has averaged 17.22% across 5 years, with a median of 21.89% in 2021.
  • Biggest five-year swings in Tax Rate: skyrocketed 62652bps in 2021 and later plummeted -4772bps in 2023.
  • Tracing ANIP's Tax Rate over 5 years: stood at 21.89% in 2021, then increased by 18bps to 25.76% in 2022, then crashed by -185bps to 21.96% in 2023, then surged by 215bps to 25.33% in 2024, then crashed by -50bps to 12.56% in 2025.
  • Business Quant data shows Tax Rate for ANIP at 12.56% in Q4 2025, 21.3% in Q3 2025, and 18.77% in Q2 2025.